The primary goal of the cardiovascular and pulmonary systems is to ensure adequate delivery of oxygen and nutrients to support target tissue. Each year 5.7 million, critically ill Americans are admitted to Intensive Care Units, the majority of which suffer from a form of shock. Shock in its many forms yields the same end effect: anaerobic cellular metabolism which results from inadequate delivery of oxygen, or improper utilization of oxygen by cells. The interstitial fluid surrounding cells is the crossroad between oxygen delivered by capillaries and oxygen utilized by cells, promising insight into both fundamental causes of shock.

OxyView™ TC utilizes phosphorescent lifetime measurements in generating display of continuous, quantitative tissue oxygenation data from the interstitial fluid. OxyView™ TC aims to empower the health care team to better diagnose, treat, and manage the critically ill. 


(202) 800-8060

Toll Free: 866-SURGISENSE

5272 River Rd Suite 200, Bethesda, MD 20816, USA


All technologies herein described are not yet approved by regulatory agencies. The devices are investigational and not available for commercial sale, or use in humans.